Market Cap 435.68M
Revenue (ttm) 0.00
Net Income (ttm) -223.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,361,400
Avg Vol 2,653,396
Day's Range N/A - N/A
Shares Out 109.19M
Stochastic %K 93%
Beta 0.45
Analysts Sell
Price Target $8.94

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogeni...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 659 8001
Address:
9 Cedarbrook Drive, Cranbury, United States
3day
3day Jul. 8 at 1:39 PM
$RCKT GET THIS MF to $6
0 · Reply
TurningAProfit
TurningAProfit Jul. 7 at 4:40 PM
$RCKT Just started following this one!
0 · Reply
user01918018374783
user01918018374783 Jul. 7 at 12:54 PM
0 · Reply
LadsAndGents
LadsAndGents Jul. 6 at 6:33 PM
$RCKT mid 7s could be the target 🎯 n next 1 month by earning date.. expecting they release new data before that $XBI $SPY
0 · Reply
StockRockCanada
StockRockCanada Jul. 6 at 5:42 PM
$RCKT With average target price of analysts being above $11 the rally has just started
0 · Reply
Wolfietrader
Wolfietrader Jul. 6 at 5:06 PM
$RCKT spicy
0 · Reply
FrodoBag
FrodoBag Jul. 6 at 5:04 PM
$RCKT any shorts out there starting to cover?
0 · Reply
alotobeer
alotobeer Jul. 6 at 4:56 PM
$RCKT get on and shut up!
0 · Reply
3effe82
3effe82 Jul. 6 at 2:56 PM
$RCKT Testing 4$ level..GL
0 · Reply
darntootin
darntootin Jul. 5 at 8:41 PM
$RCKT I’m starting to think that we may get an early surprise on the Dannon study With this new FDA greasing the tracks for drugs just like this after we dose the 3 new patients successfully what is the need to dose 9 more and wait a year we have the best long term data from the phase 1 trial 5/ 6 year survival they could file for the BLA 3rd quarter this year and have the drug out by mid 2027 like a year from now just thinking out loud I see some really good days ahead gl
0 · Reply
Latest News on RCKT
Rocket Pharmaceuticals Transcript: AGM 2026

May 20, 2026, 9:00 AM EDT - 7 weeks ago

Rocket Pharmaceuticals Transcript: AGM 2026


Rocket Pharmaceuticals reports Q1 EPS (42c) , consensus (45c)

2026-05-07T21:49:50.000Z - 2 months ago

Rocket Pharmaceuticals reports Q1 EPS (42c) , consensus (45c)


Rocket Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 2 months ago

Rocket Pharmaceuticals Quarterly report: Q1 2026


Rocket Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 2 months ago

Rocket Pharmaceuticals Earnings release: Q1 2026


Rocket Pharmaceuticals Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Rocket Pharmaceuticals Proxy statement: Proxy filing


Rocket Pharmaceuticals Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Rocket Pharmaceuticals Proxy statement: Proxy filing


Rocket Pharmaceuticals stock weakness unwarranted, says Wedbush

2026-03-27T16:10:33.000Z - 3 months ago

Rocket Pharmaceuticals stock weakness unwarranted, says Wedbush


Rocket Pharmaceuticals Transcript: FDA announcement

Mar 27, 2026, 8:30 AM EDT - 3 months ago

Rocket Pharmaceuticals Transcript: FDA announcement


Rocket Pharmaceuticals Press release: FDA announcement

Mar 27, 2026, 8:30 AM EDT - 3 months ago

Rocket Pharmaceuticals Press release: FDA announcement


Rocket Pharmaceuticals announces FDA approval of Kresladi

2026-03-27T11:05:10.000Z - 3 months ago

Rocket Pharmaceuticals announces FDA approval of Kresladi


FDA approves Rocket Pharmaceuticals’ Kresladi in LAD-I

2026-03-27T00:55:09.000Z - 3 months ago

FDA approves Rocket Pharmaceuticals’ Kresladi in LAD-I


Rocket Pharmaceuticals Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Rocket Pharmaceuticals Proxy statement: Proxy filing


Rocket Pharmaceuticals files $400M mixed securities shelf

2026-03-02T21:21:06.000Z - 4 months ago

Rocket Pharmaceuticals files $400M mixed securities shelf


Rocket Pharmaceuticals reports Q4 EPS (38c), consensus (42c)

2026-02-26T21:17:28.000Z - 4 months ago

Rocket Pharmaceuticals reports Q4 EPS (38c), consensus (42c)


Rocket Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 7:00 AM EST - 4 months ago

Rocket Pharmaceuticals Earnings release: Q4 2025


Rocket Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 7:00 AM EST - 4 months ago

Rocket Pharmaceuticals Annual report: Q4 2025


Rocket Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Rocket Pharmaceuticals Earnings release: Q3 2025


Rocket Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Rocket Pharmaceuticals Quarterly report: Q3 2025


Rocket Pharmaceuticals Slides: Corporate Presentation

Nov 6, 2025, 7:00 AM EST - 8 months ago

Rocket Pharmaceuticals Slides: Corporate Presentation


Rocket Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Rocket Pharmaceuticals Earnings release: Q2 2025


Rocket Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Rocket Pharmaceuticals Quarterly report: Q2 2025


3day
3day Jul. 8 at 1:39 PM
$RCKT GET THIS MF to $6
0 · Reply
TurningAProfit
TurningAProfit Jul. 7 at 4:40 PM
$RCKT Just started following this one!
0 · Reply
user01918018374783
user01918018374783 Jul. 7 at 12:54 PM
0 · Reply
LadsAndGents
LadsAndGents Jul. 6 at 6:33 PM
$RCKT mid 7s could be the target 🎯 n next 1 month by earning date.. expecting they release new data before that $XBI $SPY
0 · Reply
StockRockCanada
StockRockCanada Jul. 6 at 5:42 PM
$RCKT With average target price of analysts being above $11 the rally has just started
0 · Reply
Wolfietrader
Wolfietrader Jul. 6 at 5:06 PM
$RCKT spicy
0 · Reply
FrodoBag
FrodoBag Jul. 6 at 5:04 PM
$RCKT any shorts out there starting to cover?
0 · Reply
alotobeer
alotobeer Jul. 6 at 4:56 PM
$RCKT get on and shut up!
0 · Reply
3effe82
3effe82 Jul. 6 at 2:56 PM
$RCKT Testing 4$ level..GL
0 · Reply
darntootin
darntootin Jul. 5 at 8:41 PM
$RCKT I’m starting to think that we may get an early surprise on the Dannon study With this new FDA greasing the tracks for drugs just like this after we dose the 3 new patients successfully what is the need to dose 9 more and wait a year we have the best long term data from the phase 1 trial 5/ 6 year survival they could file for the BLA 3rd quarter this year and have the drug out by mid 2027 like a year from now just thinking out loud I see some really good days ahead gl
0 · Reply
darntootin
darntootin Jul. 2 at 8:30 PM
0 · Reply
Wolfietrader
Wolfietrader Jul. 2 at 7:35 PM
$RCKT you may proceed to $4
1 · Reply
alotobeer
alotobeer Jul. 2 at 2:08 PM
$RCKT get on and shut up
0 · Reply
Plowmaster
Plowmaster Jul. 2 at 4:33 AM
$RCKT still around, just after FDA news, I knew it was gonna be a while so just waiting for the next data read out! But still quite bullish!
0 · Reply
darntootin
darntootin Jul. 1 at 9:46 PM
0 · Reply
cbowers8171
cbowers8171 Jul. 1 at 8:48 PM
$RCKT ?????????????????????????????!!!!??????????
0 · Reply
Bellz22
Bellz22 Jul. 1 at 2:46 PM
0 · Reply
geegor
geegor Jun. 30 at 9:36 PM
$RCKT 8-K filing tonight, staff change, nothing material. "On June 24, John Militello informed the Company of his resignation as VP of Finance, Senior Controller, Treasurer & Principal Accounting Officer, effective July 7, 2026, to pursue other opportunities. On June 30, Joseph Manhede, the Co’s Associate Vice President, Corporate Controller, was appointed as the Co’s Principal Accounting Officer, effective July 8, 2026. Mr. Manhede, age 48, has served as the Co’s Associate VP, Corporate Controller since April 2026. Prior to Rocket, Mr. Manhede was the Vice President & Financial Controller for Outlook Therapeutics, a clinical-stage biopharmaceutical company, where he was responsible for leading accounting & finance functions... ...No new compensatory arrangements will be entered into with Mr. Manhede..." https://ir.rocketpharma.com/node/13466/html
0 · Reply
Resilience1239
Resilience1239 Jun. 30 at 8:18 PM
$RCKT quiet board........................................
1 · Reply
darntootin
darntootin Jun. 26 at 6:29 PM
$RCKT Bullish.
0 · Reply
xXCronoSXx
xXCronoSXx Jun. 26 at 1:14 PM
$RCKT soon
1 · Reply
Resilience1239
Resilience1239 Jun. 25 at 10:35 PM
1 · Reply